Geopolitics Alpha

Penumbra (PEN) Stock Faces Q3 Earnings Valuation Scrutiny

Published . Updated .

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.

GEOPOLITICS ALPHAPenumbra (PEN) Stock Faces Q3Earnings Valuation ScrutinyPENGEOPOLITICS ALPHA

This report does not map to a usual set of affected companies.

Directly affected

  • PEN Penumbra+1.0% 30d

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR holds the health sector that Penumbra belongs to, so it often moves with news about it.

  • SYK Stryker+16.7% 30d

    Stryker is a peer of Penumbra in surgical and medical instruments and apparatus; rivals often move on the same news.

  • MMM 3M+15.1% 30d

    3M is a peer of Penumbra in surgical and medical instruments and apparatus; rivals often move on the same news.

  • BSX Boston Scientific+3.8% 30d

    Boston Scientific is a peer of Penumbra in surgical and medical instruments and apparatus; rivals often move on the same news.

  • BDX Becton, Dickinson and+19.7% 30d

    Becton, Dickinson and is a peer of Penumbra in surgical and medical instruments and apparatus; rivals often move on the same news.

  • MDLN Medline+9.3% 30d

    Medline is a peer of Penumbra in surgical and medical instruments and apparatus; rivals often move on the same news.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
PEN+1.99%-0.14%base+0.80%+0.41%+1.18%+0.77%
XLV-3.03%-2.77%base-0.14%-0.48%+2.59%+0.17%
SYK+5.10%+4.38%base+5.34%+6.53%+16.59%+14.97%
MMM-0.88%-0.89%base+2.34%+1.58%+11.32%+7.71%
BSX+8.65%+1.02%base+5.62%+3.65%+9.15%+6.31%
BDX-0.73%-1.34%base+0.39%+0.20%+5.67%+7.90%
MDLN+4.92%+0.90%base+4.80%+6.26%+25.81%+23.96%

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Penumbra (PEN) Stock Faces Q3 Earnings Valuation Scrutiny Yahoo Finance

Source: Yahoo Finance

This story

CompanyWhenMoveStatus
BDXthat day+0.39%final price
BDXthe next day+0.20%final price
BDXtwo days later+5.67%final price
BDXthree days later+7.90%final price
BDXthree days earlier-1.34%final price
BDXfive days earlier-0.73%final price
BSXthat day+5.62%final price
BSXthe next day+3.65%final price
BSXtwo days later+9.15%final price
BSXthree days later+6.31%final price
BSXthree days earlier+1.02%final price
BSXfive days earlier+8.65%final price
MDLNthat day+4.80%final price
MDLNthe next day+6.26%final price
MDLNtwo days later+25.81%final price
MDLNthree days later+23.96%final price
MDLNthree days earlier+0.90%final price
MDLNfive days earlier+4.92%final price
MMMthat day+2.34%final price
MMMthe next day+1.58%final price
MMMtwo days later+11.32%final price
MMMthree days later+7.71%final price
MMMthree days earlier-0.89%final price
MMMfive days earlier-0.88%final price
PENthat day+0.80%final price
PENthe next day+0.41%final price
PENtwo days later+1.18%final price
PENthree days later+0.77%final price
PENthree days earlier-0.14%final price
PENfive days earlier+1.99%final price
SYKthat day+5.34%final price
SYKthe next day+6.53%final price
SYKtwo days later+16.59%final price
SYKthree days later+14.97%final price
SYKthree days earlier+4.38%final price
SYKfive days earlier+5.10%final price
XLVthat day-0.14%final price
XLVthe next day-0.48%final price
XLVtwo days later+2.59%final price
XLVthree days later+0.17%final price
XLVthree days earlier-2.77%final price
XLVfive days earlier-3.03%final price

Congressional trades in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

How solid “Penumbra (PEN) Stock Faces Q3 Earnings Valuation Scrutiny” looks

12 out of 100

“Penumbra (PEN) Stock Faces Q3 Earnings Valuation Scrutiny” scores 12 out of 100. The score uses 1 sources.